These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1530409

  • 1. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP, Schiele F, Bernard Y, Anguenot T.
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [Abstract] [Full Text] [Related]

  • 2. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Elements of choice of thrombolytic agents in myocardial infarction].
    Samama M, Brochet E, Valère PE.
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL.
    Rev Esp Cardiol; 1992 May; 45 Suppl 2():9-20. PubMed ID: 1475514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular function].
    Barraud P, Marcaggi X, Boueyre M, Schandrin C, Regeard E, Maublant J, Lusson JR, Cassagnes J.
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):689-95. PubMed ID: 1530410
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Verh K Acad Geneeskd Belg; 1989 May; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P, Hauert J, Iorio A, Callegari P, Agnelli G.
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Thrombolysis in acute myocardial infarct].
    Erne P.
    Ther Umsch; 1991 Aug; 48(8):527-34. PubMed ID: 1926013
    [Abstract] [Full Text] [Related]

  • 18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators.
    N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Which thrombolysis in myocardial infarction?].
    Bassand JP.
    Ann Cardiol Angeiol (Paris); 1989 Dec 30; 38(10):635-43. PubMed ID: 2698117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.